KWESST Provides Update on Key Revenue Opportunities
Ottawa, Ontario–(Newsfile Corp. – June 26, 2023) – KWESST Micro Systems Inc. (TSXV: KWE) (TSXV:…
Ottawa, Ontario–(Newsfile Corp. – June 26, 2023) – KWESST Micro Systems Inc. (TSXV: KWE) (TSXV:…
HONG KONG, Jun 26, 2023 – (ACN Newswire) – Hypebeast Limited (Stock Code: 0150.HK) is…
NEW YORK, Jun 26, 2023 – (ACN Newswire) – NAI Global has released survey results…
New outcomes demonstrate the effectiveness of Vida interventions regardless of socioeconomic barriers. SAN FRANCISCO–(BUSINESS WIRE)–New…
Smart Eye will deliver its complete hardware and software Driver Monitoring System (DMS) to Linde…
ATLANTA–(BUSINESS WIRE)–NCR Corporation (NYSE: NCR), a leading enterprise technology provider, today announced the filing of…
Non-Hodgkin’s lymphoma (NHL) is the seventh leading cause of cancer in the US, with 20-40%…
By Dave Purdy, public relations specialist at Otter PR Interviewing is an art. It…
The Phase 3 study of Ovydso was initiated in China in February 2023 and enrolled…
Promissory note extends cash runway into early Q3 2023 OLPRUVA™ expected to be available by…
BOSTON, June 26, 2023 (GLOBE NEWSWIRE) — Cerevance, a private, clinical-stage drug discovery and development…
VANCOUVER, British Columbia, June 26, 2023 (GLOBE NEWSWIRE) — Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage…
CAMBRIDGE, Mass., June 26, 2023 (GLOBE NEWSWIRE) — Wave Life Sciences Ltd. (Nasdaq: WVE), a…
ART12.11, a novel and patented cocrystal of CBD reverses the impact of chronic stress on outcomes…
Financing led by Nextech and includes participation from EcoR1 Capital, Frazier Life Sciences, Venrock Healthcare…
FREMONT, CA, June 26, 2023 (GLOBE NEWSWIRE) — via NewMediaWire — ABVC BioPharma, Inc. (NASDAQ:…
IRVINE, Calif., June 26, 2023 (GLOBE NEWSWIRE) — Reneo Pharmaceuticals, Inc. (Nasdaq: RPHM), a clinical-stage…
MINNEAPOLIS, June 26, 2023 (GLOBE NEWSWIRE) — Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage…
Twirla (levonorgestrel and ethinyl estradiol) transdermal system will be made available nationwide to members of…
Baseline Data from Phase 3 Trial of NE3107 Presented as Poster at the American Diabetes…